APA (7th ed.) Citation

A, U., SMH, F., A, E., T, R., MD, A., AZ, J., . . . HL, C. d. G. (2022). Challenges in the treatment of late-identified untreated congenital adrenal hyperplasia due to CYP11B1 deficiency: Lessons from a developing country. Frontiers in endocrinology, 13, 1015973. https://doi.org/10.3389/fendo.2022.1015973

Chicago Style (17th ed.) Citation

A, Utari, Faradz SMH, Ediati A, Rinne T, Ariani MD, Juniarto AZ, Drop SLS, van Herwaarden AE, and Claahsen-van der Grinten HL. "Challenges in the Treatment of Late-identified Untreated Congenital Adrenal Hyperplasia Due to CYP11B1 Deficiency: Lessons from a Developing Country." Frontiers in Endocrinology 13 (2022): 1015973. https://doi.org/10.3389/fendo.2022.1015973.

MLA (9th ed.) Citation

A, Utari, et al. "Challenges in the Treatment of Late-identified Untreated Congenital Adrenal Hyperplasia Due to CYP11B1 Deficiency: Lessons from a Developing Country." Frontiers in Endocrinology, vol. 13, 2022, p. 1015973, https://doi.org/10.3389/fendo.2022.1015973.